PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Income Statement
PACB / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 12.8% compound annual rate over the past 7 years.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | $78.6M | $93.5M | $90.7M | $28.2M | $60.6M | $28.2M | $26.0M | $33.9M |
| Cost of Revenue | $114.2M | $116.7M | $147.7M | $79.3M | $71.7M | $46.3M | $56.3M | $53.5M | $58.8M | $46.6M | $21.8M | $37.2M | $21.8M | $25.0M | $20.8M |
| Gross Profit | $45.8M | $37.3M | $52.8M | $49.0M | $58.9M | $32.6M | $34.6M | $25.1M | $34.7M | $44.2M | $6.4M | $23.4M | $6.4M | $940.0K | $13.0M |
| SG&A Expense | $141.5M | $175.0M | $169.8M | $160.9M | $124.1M | $72.8M | $75.5M | $63.5M | $59.1M | $47.8M | $38.7M | $38.0M | $38.7M | $47.7M | $46.7M |
| R&D Expense | $97.3M | $134.9M | $187.2M | $193.0M | $112.9M | $64.2M | $59.6M | $62.6M | $65.3M | $67.6M | $45.2M | $48.2M | $45.2M | $47.6M | $76.1M |
| Operating Income | -$553.9M | -$474.3M | -$334.5M | -$307.2M | -$210.4M | -$104.4M | -$100.5M | -$101.0M | -$89.8M | -$71.2M | -$77.5M | -$62.9M | -$77.5M | -$94.3M | -$109.8M |
| Interest Expense | - | - | $14.3M | $14.7M | $12.5M | $267.0K | $2.6M | $2.4M | $2.9M | $3.2M | $2.5M | $2.8M | $2.5M | $274.0K | $287.0K |
| Income Tax | $318.0K | $316.0K | -$11.4M | $0 | -$93.6M | - | - | - | - | - | - | - | - | - | - |
| Net Income | -$546.4M | -$309.9M | -$306.7M | -$314.2M | -$181.2M | $29.4M | -$84.1M | -$102.6M | -$92.2M | -$74.4M | -$79.3M | -$66.2M | -$79.3M | -$94.5M | -$109.4M |
| EPS (Basic) | -$1.82 | -$1.13 | -$1.21 | -$1.40 | -$0.89 | $0.18 | -$0.55 | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -$1.82 | -$1.59 | -$1.21 | -$1.40 | -$0.89 | $0.17 | -$0.55 | -$0.83 | -$0.42 | -$0.94 | -$1.26 | -$1.69 | -$2.03 | -$14.10 | -$173.03 |
| Shares Outstanding | 300.0M | 288.4M | 253.6M | 224.6M | 204.1M | 175.0M | 152.5M | 116.3M | 92.7M | 80.0M | 73.9M | 66.3M | 56.2M | 55.0K | 52.9M |
| Gross Margin | - | - | - | - | - | - | - | 31.9% | 37.1% | 48.7% | 22.8% | 38.6% | 22.8% | 3.6% | 38.5% |
| Operating Margin | - | - | - | - | - | - | - | -128.4% | -96.1% | -78.5% | -275.2% | -103.7% | -275.2% | -363.1% | -324.1% |
| Profit Margin | - | - | - | - | - | - | - | -130.4% | -98.6% | -82.0% | -281.4% | -109.2% | -281.4% | -363.6% | -323.0% |